title: Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient.
abstract: Encapsulating peritoneal sclerosis is a severe complication of peritoneal dialysis. Immunosuppressive drugs have been claimed to be helpful in the treatment of this disease, although the pathophysiological background is poorly understood. In this report, we present a patient with encapsulating peritoneal sclerosis after successful renal transplantation. Maintenance immunosuppressive therapy consisted of mycophenolate mofetil, tacrolimus, and low-dose corticosteroids. The patient was treated successfully with high doses of corticosteroids. A subsequent relapse of the encapsulating peritoneal sclerosis, probably resulting from fast tapering of the corticosteroid dose, responded well to an increase in corticosteroid dose. Our case strongly supports a therapeutic role for high-dose steroids in the treatment of encapsulating peritoneal sclerosis during its initial inflammatory stage.
authors.affiliation: Department of Nephrology and Renal Transplantation, University Hospital Leuven, Leuven, Belgium.
authors.forename: Tom
authors.initials: T
authors.lastname: Dejagere
authors.forename: Pieter
authors.initials: P
authors.lastname: Evenepoel
authors.forename: Kathleen
authors.initials: K
authors.lastname: Claes
authors.forename: Dirk
authors.initials: D
authors.lastname: Kuypers
authors.forename: Bart
authors.initials: B
authors.lastname: Maes
authors.forename: Yves
authors.initials: Y
authors.lastname: Vanrenterghem
mesh_terms: D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D012598:Sclerosis / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D000305:Adrenal Cortex Hormones